NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Mental Health Weekly Digest

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Mental Health Weekly Digest

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Addiction Medicine



Thienorphine is potent long-acting partial opioid agonist



August 28th, 2006

Thienorphine is a potent long-acting partial opioid agonist.

According to recent research published in the Journal of Pharmacology and Experimental Therapeutics, "A strategy in the development of new treatment for opioid addiction is to find partial opioid agonists with properties of long duration of action and high oral bioavailability. In a search for such compounds, thienorphine, a novel analog of buprenorphine, was synthesized."

"We report that, like buprenorphine, thienorphine bound potently and nonselectively to mu-, delta-, and kappa-opioid receptors stably expressed in CHO (Chinese hamster ovary) cells and behaved as a partial agonist...


Source: Mental Health Weekly Digest (2006-08-28)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login